OMP 20 (Omeprazole magnesium delayed-release 20 mg (base))
Pill imprint OMP 20 has been identified as Omeprazole magnesium delayed-release 20 mg (base).
Omeprazole is used in the treatment of gerd; barrett's esophagus; gastritis/duodenitis; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. Risk cannot be ruled out during pregnancy. Omeprazole 20 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
- OMP 20
- 20 mg (base)
- Pink & White
- Rx and/or OTC
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- ferrosoferric oxide
calcium phosphate dibasic anhydrous
hypromellose 2208 (3 mPa.s)
methacrylic acid - methyl methacrylate copolymer (1:2)
methacrylic acid - ethyl acrylate copolymer (1:1) type a
ferric oxide red
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
Note: Inactive ingredients may vary.
More about omeprazole
- Omeprazole delayed-release capsules
- Omeprazole delayed-release oral suspension
- Omeprazole delayed-release tablets
- Omeprazole magnesium delayed-release capsules and tablets
- More (2) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.